On October 13, Astera Labs, Inc. fell 3.1% in Pre-Market Trading, trading at $316.62 per share, with turnover of $1.2229 million.
The main catalyst was continued pressure after Northland Securities downgraded the stock to market perform from outperform, while profit-taking persisted ahead of the company’s November 3 third-quarter results release.
Recent market updates indicated that although consensus expectations remained relatively constructive, with analysts on average rating the stock overweight or buy-equivalent and assigning a mean target price of $416.78, the single-bank downgrade still weighed on near-term sentiment. The market is also expecting next-quarter EPS of $0.83, following reported EPS of $0.49 in the prior quarter.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)